NLS Pharmaceutics Ltd. (NASDAQ: NLSP)
$0.20
-0.0043 ( -2.10% ) 515.8K
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
Market Data
Open
$0.20
Previous close
$0.21
Volume
515.8K
Market cap
$9.48M
Day range
$0.20 - $0.21
52 week range
$0.11 - $1.21
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Mar 14, 2024 |
6-k | Quarterly Reports | 3 | Mar 11, 2024 |
6-k | Quarterly Reports | 3 | Feb 23, 2024 |
6-k | Quarterly Reports | 3 | Jan 12, 2024 |
6-k | Quarterly Reports | 3 | Dec 29, 2023 |
6-k | Quarterly Reports | 1 | Dec 22, 2023 |
6-k | Quarterly Reports | 51 | Dec 06, 2023 |
6-k | Quarterly Reports | 3 | Dec 04, 2023 |
6-k | Quarterly Reports | 4 | Dec 04, 2023 |
6-k | Quarterly Reports | 3 | Dec 01, 2023 |